Measurement of Sickle Cell Disease Symptoms from the Patient Perspective: Considerations for Clinical Trials

被引：2
|
作者：
Ojo, Funke [1 ]
Litcher-Kelly, Leighann [2 ]
Mazar, Iyar [2 ]
Klooster, Brittany [2 ]
Ollis, Sarah [2 ]
Chaston, Emily [2 ]
Roeder, Adam [2 ]
Treadwell, Marsha J. [3 ]
Reasner, David [1 ]
机构：
[1] Ironwood Pharmaceut, Cambridge, MA USA
[2] Adelphi Values, Boston, MA USA
[3] UCSF Benioff Childrens Hosp Oakland, Hematol Oncol, Oakland, CA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116682
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3571
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ALIGNMENT BETWEEN PATIENT-PRIORITIZED SYMPTOMS AND ENDPOINTS USED IN CLINICAL TRIALS: A CASE STUDY ON SICKLE CELL DISEASE
    Oehrlein, E. M.
    Ganser, T. R.
    Perfetto, E. M.
    Ziadeh, M.
    El-Gendi, S.
    Ghorashi, B.
    El-Gendi, H.
    Hanna, M. L.
    Bjoernebo, L.
    VALUE IN HEALTH, 2017, 20 (05) : A228 - A228
  • [2] Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease
    Hood, Anna M.
    Crosby, Lori E.
    Stotesbury, Hanne
    Kolbel, Melanie
    Kirkham, Fenella J.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [3] Sickle cell disease - Pathogenic, clinical and therapeutic considerations
    Bauer, J
    ARCHIVES OF SURGERY, 1940, 41 (06) : 1344 - 1362
  • [4] Neurologic symptoms in a patient with sickle cell disease: when is it not a stroke?
    Taylor, E.
    Revanna, P.
    Jm, Mack
    Mayo, R.
    Cox, C.
    Slate, R.
    Parkey, A.
    Saccente, S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2025, 369 : S249 - S250
  • [5] Trials in sickle cell disease
    Kirkham, Fenella J.
    Lerner, Norma B.
    Noetzel, Michael
    DeBaun, Michael R.
    Datta, Avijit K.
    Rees, David C.
    Adams, Robert J.
    PEDIATRIC NEUROLOGY, 2006, 34 (06) : 450 - 458
  • [6] Exploring the Patient Perspective of Gene Therapy for Sickle Cell Disease
    Nimura, Clare
    Gonzalez, Lisbel
    Brown, Tatum
    Van Doren, Layla N.
    Karkoska, Kristine
    Jacob, Seethal A.
    Azar, Sharl
    Boucher, Alexander A.
    Mcgann, Patrick T.
    BLOOD, 2024, 144 : 4999 - 5000
  • [7] Mistrust of Pediatric Sickle Cell Disease Clinical Trials Research
    Stevens, Evelyn M.
    Patterson, Chavis A.
    Li, Yimei B.
    Smith-Whitley, Kim
    Barakat, Lamia P.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2016, 51 (01) : S78 - S86
  • [8] Sickle Cell Disease, 2015 A Patient Advocate's Perspective
    Williams, Andrea M.
    Smith-Whitley, Kim
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2016, 51 (01) : S5 - S9
  • [9] National Emergency Cards for Sickle Cell Disease: A Survey on Usefulness from the Patient Perspective
    Bruce, Aisha Aiko
    Bolster, Lauren
    Corriveau-Bourque, Catherine
    Dang, Michelle
    Alotaibi, Ghazi S.
    McGrath, Maria
    Venner, Mary Anne
    Ezzat, Hatoon M.
    BLOOD, 2019, 134
  • [10] End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain
    Farrell, Ann T.
    Panepinto, Julie
    Carroll, C. Patrick
    Darbari, Deepika S.
    Desai, Ankit A.
    King, Allison A.
    Adams, Robert J.
    Barber, Tabitha D.
    Brandow, Amanda M.
    DeBaun, Michael R.
    Donahue, Manus J.
    Gupta, Kalpna
    Hankins, Jane S.
    Kameka, Michelle
    Kirkham, Fenella J.
    Luksenburg, Harvey
    Miller, Shirley
    Oneal, Patricia Ann
    Rees, David C.
    Setse, Rosanna
    Sheehan, Vivien A.
    Strouse, John
    Stucky, Cheryl L.
    Werner, Ellen M.
    Wood, John C.
    Zempsky, William T.
    BLOOD ADVANCES, 2019, 3 (23) : 3982 - 4001
12345